Improving discharge care for preterm infants with lung disease
Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease
This study is testing a new care plan for preterm infants with lung disease to see if it helps them transition better from the hospital to home and improves their health and parents' satisfaction.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 0 Days to 1 Year |
| Sex | All |
| Sponsor | Boston Children's Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Trial ID | NCT05285345 on ClinicalTrials.gov |
What this trial studies
This study evaluates the implementation of a consensus-based discharge protocol for preterm infants with bronchopulmonary dysplasia (BPD) at Boston Children's Hospital and its collaborating NICUs. The research aims to assess follow-up rates, healthcare utilization, and parental satisfaction before and after the protocol's enactment. By establishing guidelines for the transition of care from the NICU to home, the study seeks to improve outcomes for this vulnerable population. The focus is on infants born before 32 weeks gestation who have at least mild BPD.
Who should consider this trial
Good fit: Ideal candidates are preterm infants born before 32 weeks gestation with at least mild bronchopulmonary dysplasia.
Not a fit: Patients discharged to locations other than home or those with significant congenital diseases affecting their respiratory condition may not benefit from this study.
Why it matters
Potential benefit: If successful, this protocol could enhance care coordination and reduce hospitalizations for preterm infants with lung disease.
How similar studies have performed: Other studies have shown that coordinated follow-up programs can improve outcomes for preterm infants, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Preterm infants born \<32 weeks with at least mild BPD, defined as 28 days of respiratory support after birth. * Efforts will be made to include a mix of infants with mild, moderate, and severe BPD, including infants discharged on oxygen. Exclusion Criteria: * Discharge to a location other than home. * Infants with other congenital disease (cardiac, genetic, neurological) thought to contribute significantly to their respiratory disease.
Where this trial is running
Boston, Massachusetts
- Boston Children's Hospital — Boston, Massachusetts, United States (Recruiting)
Study contacts
- Principal investigator: Jonathan Levin, MD — Boston Children's Hospital
- Study coordinator: Jonathan Levin, MD
- Email: jonathan.levin@childrens.harvard.edu
- Phone: 617-355-1900
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.